合并性颅内出血亚型不应改变改良脑损伤指南标准
该回顾性研究纳入两家一级创伤中心2017年1月1日至2023年6月30日收治的844例成人mBIG 1或2级创伤性颅内出血患者,其中251例(29.7%)为合并性颅内出血(≥2种亚型)。与孤立性出血相比,合并性出血患者损伤严重度评分更高(14.3 vs 11.8,p<0.001)、ICU住院时间更长(1 vs 0天,p<0.001)、影像学进展更多(20.3% vs 11.3%,p=0.002),但临床恶化(1.0% vs 2.6%,p=0.252)、神经外科干预(0.4% vs 0.2%,p=0.507)和再入院(5.2% vs 3.7%,p=0.413)均罕见且无显著差异。作者结论支持对孤立性和合并性颅内出血继续使用mBIG分诊,仅在神经功能恶化或其他高危特征时升级治疗。证据等级为治疗/管理类,Level IV。
要点
- 在mBIG 1或2级患者中,合并性颅内出血(≥2种亚型)占29.7%(251/844),其临床恶化率仅1.0%,与孤立性出血的2.6%无显著差异(p=0.252)。
- 合并性出血的神经外科干预率为0.4%,孤立性出血为0.2%,两组均极低且无显著差异(p=0.507),不支持仅因合并亚型而升级分诊。
- 合并性出血的影像学进展更高(20.3% vs 11.3%,p=0.002),ICU住院时间更长(1 vs 0天,p<0.001),但未转化为临床恶化或干预增加。
- 作者结论支持对孤立性和合并性颅内出血继续沿用mBIG分诊,将升级治疗保留给神经功能恶化或其他高危特征。
适用人群与场景
- 成人创伤性颅内出血患者,按mBIG标准分类为mBIG 1或mBIG 2级,收治于两家一级创伤中心(2017年1月1日至2023年6月30日)。
- 合并性颅内出血定义为≥2种颅内出血亚型;与孤立性颅内出血(单一亚型)进行比较。
诊断标准与关键阈值
- 使用改良脑损伤指南(mBIG)进行分诊,纳入mBIG 1或mBIG 2级患者;mBIG不分合并性与孤立性颅内出血。
红旗征与不能漏的情况
- 临床恶化定义为新发局灶性神经功能缺损、瞳孔检查改变或格拉斯哥昏迷评分<13(与初诊时相比)。
- 作者认为升级治疗应保留给神经功能恶化或其他高危特征。
研究设计与关键结果
- 回顾性研究,纳入两家一级创伤中心844例成人mBIG 1或2级创伤性颅内出血患者,其中251例(29.7%)为合并性颅内出血。
- 合并性出血组 vs 孤立性出血组:损伤严重度评分14.3 vs 11.8(p<0.001),ICU住院时间1天 vs 0天(p<0.001),影像学进展20.3% vs 11.3%(p=0.002)。
- 临床恶化:合并性出血组1.0% vs 孤立性出血组2.6%(p=0.252),无显著差异。
- 神经外科干预:合并性出血组0.4% vs 孤立性出血组0.2%(p=0.507),无显著差异。
- 再入院:合并性出血组5.2% vs 孤立性出血组3.7%(p=0.413),无显著差异。
证据类型、等级与局限
- 证据类型:回顾性研究;证据等级:治疗/管理类,Level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于mBIG 1或2级创伤性颅内出血患者,合并性出血亚型不应单独作为改变mBIG分诊或升级治疗的理由;作者支持继续使用mBIG分诊。
- 合并性出血患者影像学进展和ICU资源使用更多,但临床恶化和神经外科干预罕见,提示应依据神经功能恶化或其他高危特征而非出血亚型数量来决定是否升级治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The modified Brain Injury Guidelines (mBIG) are an established protocol to triage traumatic brain injury with intracranial hemorrhage (ICH) while reducing resource utilization. However, mBIG do not differentiate between isolated and combined intracranial hemorrhage (cICH). This study evaluated whether patients with multiple ICH subtypes require different triage.
METHODS: We performed a retrospective study of adult patients classified as mBIG 1 or mBIG 2 at two Level I trauma centers January 1, 2017, to June 30, 2023. Patients with cICH (≥2 subtypes) were compared with isolated ICH. Primary outcome was clinical deterioration, defined as new focal neurologic findings, pupillary examination changes or Glasgow Coma Scale score of <13 as compared with initial presentation. Secondary outcomes included radiographic progression, neurosurgical consultation, neurosurgical intervention, number of head computed tomography, hospital and intensive care unit length of stay, and readmission.
RESULTS: Among 844 patients, 251 (29.7%) had cICH. Compared with isolated, cICH patients had higher Injury Severity Score (14.3 vs. 11.8, p < 0.001), longer intensive care unit length of stay (1 vs. 0, p < 0.001), and greater radiographic progression (20.3% vs. 11.3%, p = 0.002). However, clinical deterioration (1.0% vs. 2.6%, p = 0.252), neurosurgical intervention (0.4% vs. 0.2% p = 0.507), and readmission (5.2% vs. 3.7%, p = 0.413) were rare and did not differ between groups.
CONCLUSION: While cICH is associated with more radiographic progression and resource utilization compared with isolated ICH, it is not associated with higher occurrence of clinical deterioration or neurosurgical intervention. These findings support continued use of mBIG for isolated and cICH with escalation of care reserved for neurological deterioration or other high-risk features.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.
参考来源
- Johnson EH, Lee JS, Cripps MW, et al. Combined intracranial hemorrhage subtypes should not change modified Brain Injury Guidelines criteria. J Trauma Acute Care Surg. 2026. PMID: 41670407. doi:10.1097/TA.0000000000004864
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。